中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2024-06-302024-03-312023-12-312023-09-302023-06-30
营业总收入(万元)21875.6710832.2583551.0074612.7965697.62
营业收入(万元)21875.6710832.2583551.0074612.7965697.62
营业总成本(万元)22834.9211160.4751716.2336644.7826777.45
营业成本(万元)16505.147998.6635195.2522573.6916144.78
净利润(万元)-177.93206.8424094.6431319.0830953.29
归属于母公司的净利润(万元)-177.93206.8424307.2731319.0830953.29
营业利润(万元)-114.87247.6932168.3938189.6139761.99
利润总额(万元)-133.33245.2231653.3437961.5139558.43
少数股东损益(万元)----------
基本每股收益(元)-0.01(元)0.02(元)1.93(元)2.49(元)2.46(元)
稀释每股收益(元)-0.01(元)0.02(元)1.93(元)2.49(元)2.46(元)
非经常性损益(万元)618.77------537.17
扣除非经常性损益后净利润(万元)-796.70-64.1423197.0230427.8130416.13
总资产(万元)176862.92181886.85183899.46186173.13188960.80
总负债(万元)19877.2821352.8223572.2718988.9223231.76
归属于母公司股东权益合计(万元)156985.64160534.03160327.19167184.21165729.04
股东权益合计(万元)156985.64160534.03160327.19167184.21165729.04
实收资本(股本)(万元)12654.4512654.4512654.4512600.0012600.00
资本公积(万元)62111.0062111.0062111.0061798.0360708.64
未分配利润(万元)75553.8779102.2578895.4186835.8386470.04
经营活动产生的现金流量净额(万元)5995.985214.552695.345259.164971.54
经营活动现金流入小计(万元)24474.5613705.6469039.9461337.1750281.48
经营活动现金流出小计(万元)18478.598491.0966344.6156078.0145309.93
投资活动产生的现金流量净额(万元)902.7310603.27-12860.762553.30-17406.92
投资活动现金流入小计(万元)26203.3719146.17129661.25124133.1880355.58
投资活动现金流出小计(万元)25300.648542.90142522.02121579.8897762.50
筹资活动产生的现金流量净额(万元)-3158.34---6907.23-9069.65-9069.65
筹资活动现金流入小计(万元)5.27--2160.03----
筹资活动现金流出小计(万元)3163.61--9067.269069.659069.65
期末现金及现金等价物余额(万元)16871.4228916.8313073.3328877.828629.99
最后修改日期2024-08-262024-04-222024-04-222023-10-242023-08-27
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。